Cancer Incidence and Mortality among Hispanics, Kings County (Brooklyn), 2004-2008
Source: New York State Cancer Registry
| Site of Cancer | Incidence | Mortality | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Males | Females | Males | Females | |||||||||
| Average Annual Cases | Rate per 100,000 Males | 95% CI (+/-) | Average Annual Cases | Rate per 100,000 Females | 95% CI (+/-) | Average Annual Deaths | Rate per 100,000 Males | 95% CI (+/-) | Average Annual Deaths | Rate per 100,000 Females | 95% CI (+/-) | |
| All Invasive Malignant Tumors | 676.6 | 463.6 | 17.1 | 651.0 | 311.8 | 11.0 | 225.6 | 178.7 | 11.5 | 210.6 | 108.6 | 6.7 |
| Oral cavity and pharynx | 25.8 | 15.9 | 2.9 | 10.2 | 4.7 | 1.3 | 7.4 | 5.4 | 1.9 | 2.6 | 1.3 | 0.7 |
| Esophagus | 9.2 | 6.3 | 1.9 | 3.8 | 1.9 | 0.9 | 6.4 | 4.0 | 1.4 | 3.2 | 1.8 | 0.9 |
| Stomach | 23.8 | 17.4 | 3.4 | 16.8 | 8.5 | 1.9 | 12.2 | 9.5 | 2.6 | 7.6 | 4.1 | 1.3 |
| Colorectal | 84.8 | 59.9 | 6.3 | 72.8 | 37.0 | 3.9 | 28.8 | 23.4 | 4.2 | 27.8 | 14.7 | 2.5 |
| Colon excluding rectum | 53.4 | 40.0 | 5.3 | 52.6 | 27.1 | 3.3 | 24.6 | 19.8 | 3.8 | 23.4 | 12.4 | 2.3 |
| Rectum & rectosigmoid | 31.4 | 19.9 | 3.4 | 20.2 | 9.9 | 2.0 | 4.2 | 3.5 | 1.7 | 4.4 | 2.3 | 1.0 |
| Liver / intrahepatic bile duct | 33.0 | 20.2 | 3.3 | 13.0 | 6.4 | 1.6 | 22.8 | 14.8 | 3.0 | 9.2 | 5.0 | 1.5 |
| Pancreas | 15.6 | 11.7 | 2.9 | 18.0 | 9.2 | 1.9 | 9.4 | 7.5 | 2.4 | 14.2 | 7.6 | 1.8 |
| Larynx | 13.2 | 8.2 | 2.1 | 2.8 | 1.2 | 0.7 | 4.2 | 2.9 | 1.3 | 0.6 | 0.3 | 0.4 |
| Lung and bronchus | 67.8 | 48.8 | 5.6 | 46.6 | 23.9 | 3.1 | 48.6 | 38.2 | 5.3 | 28.4 | 14.8 | 2.5 |
| Melanoma of the skin | 5.8 | 4.0 | 1.6 | 4.2 | 2.0 | 0.9 | 0.8 | 0.4 | 0.4 | 1.2 | 0.7 | 0.5 |
| Female breast | 169.6 | 78.9 | 5.4 | 40.0 | 19.0 | 2.7 | ||||||
| Cervix uteri | 23.6 | 10.8 | 2.0 | 7.4 | 3.4 | 1.1 | ||||||
| Corpus uterus and NOS | 50.4 | 23.3 | 2.9 | 8.6 | 4.4 | 1.3 | ||||||
| Ovary | 21.8 | 9.7 | 1.9 | 14.4 | 7.1 | 1.7 | ||||||
| Prostate | 191.4 | 136.4 | 9.3 | 26.0 | 28.9 | 5.3 | ||||||
| Testis | 6.2 | 2.2 | 0.8 | 0.4 | 0.1 | 0.2 | ||||||
| Urinary bladder (incl. in situ) | 26.6 | 21.9 | 4.1 | 14.4 | 7.8 | 1.8 | 3.4 | 4.0 | 2.0 | 2.2 | 1.3 | 0.8 |
| Kidney and renal pelvis | 22.8 | 15.0 | 3.0 | 14.2 | 6.6 | 1.6 | 5.2 | 4.0 | 1.7 | 2.6 | 1.5 | 0.8 |
| Brain and other nervous system | 11.6 | 6.4 | 1.8 | 9.2 | 4.0 | 1.2 | 4.4 | 3.2 | 1.5 | 3.0 | 1.4 | 0.7 |
| Thyroid | 6.2 | 3.4 | 1.3 | 28.4 | 12.0 | 2.0 | 0.4 | 0.2 | 0.3 | 1.6 | 0.9 | 0.6 |
| Hodgkin lymphoma | 9.0 | 4.0 | 1.2 | 6.4 | 2.5 | 0.9 | 1.2 | 0.9 | 0.8 | 1.4 | 0.7 | 0.5 |
| Non-Hodgkin lymphomas | 32.2 | 21.6 | 3.7 | 31.6 | 15.0 | 2.4 | 9.0 | 7.1 | 2.3 | 8.8 | 4.7 | 1.4 |
| Multiple myeloma | 13.2 | 9.6 | 2.5 | 11.4 | 6.1 | 1.6 | 4.6 | 3.8 | 1.7 | 4.0 | 2.2 | 1.0 |
| Leukemias | 17.2 | 9.6 | 2.3 | 14.6 | 6.8 | 1.6 | 8.4 | 4.9 | 1.6 | 6.0 | 3.1 | 1.1 |
Notes
- Incidence data are provisional, November 2010.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.
